AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11705075 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentaglobin
Number of subjects: 39
Study 11705075 — intervention group
Group type: COMPARATOR
Intervention: Pentaglobin and Control
Number of subjects: 39
Study 9156146 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids
Number of subjects: 0
Study 7705155 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate-adaptive pacing
Number of subjects: 30
Study 7705155 — intervention group
Group type: COMPARATOR
Intervention: Fixed-rate pacing
Number of subjects: 30
Study 2655491 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjuvac injections (11 weekly injections of increasing concentrations from 56 x 10(1) to 448 10(3) IU D. pteronyssinus)
Number of subjects: 66
Study 2655491 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections (alginate diluent with some containing 5 micrograms of histamine)
Number of subjects: 66
Study 921867 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% lignocaine with a radio-opaque substance
Number of subjects: 0
Study 921867 — intervention group
Group type: COMPARATOR
Intervention: Caudal extradural blocks with different local anaesthetic agents
Number of subjects: 0
Study 31883621 — intervention group
Group type: EXPERIMENTAL
Intervention: M‐Wire Reciproc
Number of subjects: 26
Study 31883621 — intervention group
Group type: COMPARATOR
Intervention: Reciproc Blue
Number of subjects: 26
Study 31489422 — intervention group
Group type: EXPERIMENTAL
Intervention: HCQ+modified Xiaoyao pill
Number of subjects: 60
Study 31489422 — intervention group
Group type: COMPARATOR
Intervention: HCQ
Number of subjects: 60
Study 28387540 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 FA supplementation
Number of subjects: 26
Study 28387540 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 25499599 — intervention group
Group type: EXPERIMENTAL
Intervention: Early physiotherapy intervention combined with a therapeutic education program (n=76)
Number of subjects: 153
Study 25499599 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic education program only (control group, n=77)
Number of subjects: 153
Study 25574800 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol at an effect-site concentration of 2.5 µg/mL combined with remifentanil (0.25 to 0.35 μg/kg/min) and cisatracurium (0.03 to 0.04 mg/kg/h)
Number of subjects: 40
Study 25574800 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane at 0.5 MAC combined with remifentanil (0.25 to 0.35 μg/kg/min) and cisatracurium (0.03 to 0.04 mg/kg/h)
Number of subjects: 40
Study 24215386 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of at least three new nutrition practice changes and three new nutrition policies.
Number of subjects: 1176
Study 24215386 — intervention group
Group type: EXPERIMENTAL
Intervention: Introduction of mostly healthful foods in competitive venues at lunch.
Number of subjects: 1176
Study 24215386 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 1176
Study 20605091 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (ascorbic acid 120 mg, vitamin E 30 mg, β-carotene 6 mg, selenium 100 μg, zinc 20 mg)
Number of subjects: 12741
Study 20605091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12741
Study 20605091 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 12741
Study 18823440 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocytapheresis (GCAP)
Number of subjects: 80
Study 18823440 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (MP)
Number of subjects: 80
Study 16651490 — intervention group
Group type: EXPERIMENTAL
Intervention: Test characteristics (TC)
Number of subjects: 1502
Study 16651490 — intervention group
Group type: EXPERIMENTAL
Intervention: Test characteristics defined (TC defined)
Number of subjects: 1502
Study 16651490 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1502
Study 12823330 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD children
Number of subjects: 64
Study 12823330 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-clinical hyperactive children
Number of subjects: 64
Study 12823330 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 64
Study 12823330 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD children with comorbid ODD
Number of subjects: 64
Study 10815156 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy for Retinopathy of Prematurity (CRYO‐ROP)
Number of subjects: 766
Study 9403646 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (10.3 ± 1.9 mg/kg)
Number of subjects: 116
Study 9403646 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (9.8 ± 1.9 mg/kg)
Number of subjects: 116
Study 8130296 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal biofeedback (TBF) - 16 sessions of hand and foot warming
Number of subjects: 33
Study 8130296 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontal EMG biofeedback - 16 sessions
Number of subjects: 33
Study 8130296 — intervention group
Group type: COMPARATOR
Intervention: Regular home monitoring of BP
Number of subjects: 33
Study 8130296 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions combined
Number of subjects: 33
Study 3654237 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured educational program
Number of subjects: 26
Study 3654237 — intervention group
Group type: COMPARATOR
Intervention: No structured educational interventions (Control)
Number of subjects: 26
Study 28868810 — intervention group
Group type: EXPERIMENTAL
Intervention: Genous endothelial progenitor cell capturing stent (ECS)
Number of subjects: 193
Study 28868810 — intervention group
Group type: COMPARATOR
Intervention: TAXUS Liberté paclitaxel‐eluting stent (PES)
Number of subjects: 193
Study 28028649 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified extradiaphragmatic thoracolumbar approach
Number of subjects: 106
Study 28028649 — intervention group
Group type: COMPARATOR
Intervention: Traditional transdiaphragmatic thoracolumbar approach
Number of subjects: 106
Study 24337670 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycaemia (BGL elevated to 16.7 ± 0.9 mmol L(‐1))
Number of subjects: 12
Study 24337670 — intervention group
Group type: COMPARATOR
Intervention: Control (BGL maintained at 5.5 ± 0.1 mmol L(‐1))
Number of subjects: 12
Study 24279294 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week dog-based physical activity intervention
Number of subjects: 28
Study 24279294 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 20675882 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholinesterase inhibitors
Number of subjects: 0
Study 20675882 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 0
Study 20675882 — intervention group
Group type: EXPERIMENTAL
Intervention: Other drugs and newly developed drugs
Number of subjects: 0
Study 19030637 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glucose
Number of subjects: 76
Study 19030637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 19030637 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 76
Study 19030637 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA
Number of subjects: 76
Study 16098704 — intervention group
Group type: EXPERIMENTAL
Intervention: GALM program (15 sessions of 60 min each, once a week)
Number of subjects: 181
Study 16098704 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 181
Study 16098704 — intervention group
Group type: EXPERIMENTAL
Intervention: GALM program
Number of subjects: 181
Study 14511968 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured one‐to‐one in‐hospital education session
Number of subjects: 106
Study 14511968 — intervention group
Group type: COMPARATOR
Intervention: Usual verbal encouragement (Control)
Number of subjects: 106
Study 10803620 — intervention group
Group type: EXPERIMENTAL
Intervention: Innervated flaps
Number of subjects: 12
Study 10803620 — intervention group
Group type: COMPARATOR
Intervention: Non-innervated flaps
Number of subjects: 12
Study 8849259 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofx2 (2 days of oral ofloxacin treatment at 15 mg/kg/day)
Number of subjects: 108
Study 8849259 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofx3 (3 days of oral ofloxacin treatment at 15 mg/kg/day)
Number of subjects: 108
Study 7950227 — intervention group
Group type: EXPERIMENTAL
Intervention: Baluodan (BLD)
Number of subjects: 210
Study 3627086 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 ppm CO exposure
Number of subjects: 0
Study 3627086 — intervention group
Group type: COMPARATOR
Intervention: Room air (control)
Number of subjects: 0
Study 29648854 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study 26576819 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 198
Study 26576819 — intervention group
Group type: COMPARATOR
Intervention: Hatha yoga
Number of subjects: 198
Study 26576819 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 198
Study 24107607 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-vegetable choice (carrots and beans)
Number of subjects: 100
Study 24107607 — intervention group
Group type: COMPARATOR
Intervention: One-vegetable choice (carrots)
Number of subjects: 100
Study 24107607 — intervention group
Group type: COMPARATOR
Intervention: One-vegetable choice (beans)
Number of subjects: 100
Study 22909369 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrowband UVB (NBUVB)
Number of subjects: 56
Study 22909369 — intervention group
Group type: COMPARATOR
Intervention: Oral PUVA
Number of subjects: 56
Study 20232583 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid (ALA) plus 532 nm KTP laser
Number of subjects: 8
Study 20232583 — intervention group
Group type: COMPARATOR
Intervention: 532 nm KTP laser alone
Number of subjects: 8
Study 18219455 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenyi Capsule
Number of subjects: 133
Study 18219455 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (Shenyi Capsule plus chemotherapy)
Number of subjects: 133
Study 18219455 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 133
Study 15681495 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone (250 mug/day)
Number of subjects: 50
Study 15681495 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg/day)
Number of subjects: 50
Study 15681495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 12952502 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen FluMist™
Number of subjects: 1300
Study 12952502 — intervention group
Group type: COMPARATOR
Intervention: Liquid FluMist™
Number of subjects: 1300
Study 10994218 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based care by nurses
Number of subjects: 0
Study 8856254 — intervention group
Group type: EXPERIMENTAL
Intervention: Regenerated cellulose membranes (RC group)
Number of subjects: 0
Study 8856254 — intervention group
Group type: COMPARATOR
Intervention: Polysulfone membranes (PS group)
Number of subjects: 0
Study 1826008 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) administration (12 IU sc at 2000 h for 14 days)
Number of subjects: 8
Study 1826008 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) administration
Number of subjects: 8
Study 1826008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 6640551 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐FU at a dose of 500 mg/m2/day by iv push X 5 (F)
Number of subjects: 167
Study 6640551 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐FU at a dose of 400 mg/m2/day iv X 5 plus TZT at a dose of 175 mg/m2/day iv X 3 (FT)
Number of subjects: 167
Study 6640551 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐FU at a dose of 400 mg/m2/day plus ICRF‐159 at a dose of 600 mg/m2/day orally X 3 (FI)
Number of subjects: 167
Study 6640551 — intervention group
Group type: EXPERIMENTAL
Intervention: MeCCNU at a dose of 150 mg/m2/day orally plus TZT at a dose of 200 mg/m2/day iv X 3 (MT)
Number of subjects: 167
Study 6640551 — intervention group
Group type: EXPERIMENTAL
Intervention: MeCCNU at a dose of 150 mg/m2 orally plus ICRF‐159 at a dose of 500 mg/m2/day orally X 3 (MI)
Number of subjects: 167
Study 6640551 — intervention group
Group type: EXPERIMENTAL
Intervention: ICRF‐159 at a dose of 425 mg/m2/day orally X 3 plus TZT at a dose of 125 mg/m2/day iv X 3 (IT)
Number of subjects: 167
Study 6640551 — intervention group
Group type: COMPARATOR
Intervention: 5‐FU alone (Control)
Number of subjects: 167
Study 31667735 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate tablet (single oral dose, 110 mg)
Number of subjects: 196
Study 31667735 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate tablet (single oral dose, 110 mg) with rabeprazole pretreatment (20 mg once daily for 5 days)
Number of subjects: 196
Study 31667735 — intervention group
Group type: COMPARATOR
Intervention: Dabigatran etexilate capsule (single oral dose, 110 mg)
Number of subjects: 196
Study 31034525 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced gelatine/electrolyte solution
Number of subjects: 40
Study 31034525 — intervention group
Group type: COMPARATOR
Intervention: Non-balanced gelatine/electrolyte solution
Number of subjects: 40
Study 30176970 — intervention group
Group type: EXPERIMENTAL
Intervention: Home sleep apnea testing (HSAT)
Number of subjects: 265
Study 27619049 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-shaft tympanostomy ventilation tubes
Number of subjects: 400
Study 27619049 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-shaft tympanostomy ventilation tubes
Number of subjects: 400
Study 27619049 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroplastic tympanostomy ventilation tubes
Number of subjects: 400
Study 27619049 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone tympanostomy ventilation tubes
Number of subjects: 400
Study 24955495 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy beverage preload
Number of subjects: 107
Study 24955495 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy solid food preload
Number of subjects: 107
Study 24955495 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy beverage preload
Number of subjects: 107
Study 24955495 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy solid food preload
Number of subjects: 107
Study 24955495 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning intervention
Number of subjects: 107
Study 24955495 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality and eating behavior questionnaires
Number of subjects: 107
Study 22424116 — intervention group
Group type: EXPERIMENTAL
Intervention: Bottle A (n = 29)
Number of subjects: 63
Study 22424116 — intervention group
Group type: COMPARATOR
Intervention: Bottle B (n = 25)
Number of subjects: 63
Study 22424116 — intervention group
Group type: EXPERIMENTAL
Intervention: Bottle A
Number of subjects: 63
Study 22424116 — intervention group
Group type: COMPARATOR
Intervention: Bottle B
Number of subjects: 63
Study 22424116 — intervention group
Group type: COMPARATOR
Intervention: Breast-fed reference group
Number of subjects: 63
Study 18207457 — intervention group
Group type: EXPERIMENTAL
Intervention: Exhaled breath condensate (EBC) IL-10
Number of subjects: 90
Study 18207457 — intervention group
Group type: EXPERIMENTAL
Intervention: Exhaled breath condensate (EBC) IL-6
Number of subjects: 90
Study 18207457 — intervention group
Group type: COMPARATOR
Intervention: Smoker control group
Number of subjects: 90
Study 17192292 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole and FSH
Number of subjects: 523
Study 17192292 — intervention group
Group type: COMPARATOR
Intervention: FSH only
Number of subjects: 523
Study 15167461 — intervention group
Group type: EXPERIMENTAL
Intervention: CollaCote‐epinephrine
Number of subjects: 48
Study 15167461 — intervention group
Group type: COMPARATOR
Intervention: CollaCote‐saline
Number of subjects: 48
Study 15167461 — intervention group
Group type: COMPARATOR
Intervention: Control (CollaCote‐saline)
Number of subjects: 48
Study 11838001 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT‐Ds
Number of subjects: 200
Study 11838001 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT‐Ms
Number of subjects: 200
Study 11838001 — intervention group
Group type: COMPARATOR
Intervention: RCT‐Ds and RCT‐Ms
Number of subjects: 200
Study 9616507 — intervention group
Group type: EXPERIMENTAL
Intervention: Turbuhaler (50 micrograms dose -1)
Number of subjects: 86
Study 9616507 — intervention group
Group type: COMPARATOR
Intervention: pMDI (100 micrograms dose -1) with spacer (Volumatic)
Number of subjects: 86
Study 9616507 — intervention group
Group type: EXPERIMENTAL
Intervention: Turbuhaler
Number of subjects: 86
Study 9616507 — intervention group
Group type: COMPARATOR
Intervention: pMDI
Number of subjects: 86
Study 8018402 — intervention group
Group type: EXPERIMENTAL
Intervention: haemoglobin level (B‐Hb)
Number of subjects: 198
Study 8018402 — intervention group
Group type: EXPERIMENTAL
Intervention: disease‐free interval
Number of subjects: 198
Study 8018402 — intervention group
Group type: EXPERIMENTAL
Intervention: Karnofsky performance status (KPS)
Number of subjects: 198
Study 8018402 — intervention group
Group type: EXPERIMENTAL
Intervention: number of symptoms
Number of subjects: 198
Study 8018402 — intervention group
Group type: EXPERIMENTAL
Intervention: primary tumour removal
Number of subjects: 198
Study 8018402 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐aspartate aminotransferase (S‐ASAT)
Number of subjects: 198
Study 2672900 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC)
Number of subjects: 40
Study 2672900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 895434 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine (24 mg)
Number of subjects: 21
Study 895434 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 21
Study 31190492 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular point pressing
Number of subjects: 93
Study 31190492 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 93
Study 31190492 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of auricular point pressing and EA
Number of subjects: 93
Study 27749094 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.9% sodium chloride)
Number of subjects: 974
Study 27749094 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced crystalloids (lactated Ringer's solution or Plasma‐Lyte A)
Number of subjects: 974
Study 26690033 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia training group (IHTG)
Number of subjects: 18
Study 26690033 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 18
Study 23622562 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep anterior lamellar keratoplasty (DALK)
Number of subjects: 54
Study 23622562 — intervention group
Group type: COMPARATOR
Intervention: Penetrating keratoplasty (PK)
Number of subjects: 54
Study 20693248 — intervention group
Group type: EXPERIMENTAL
Intervention: Dornase alfa
Number of subjects: 17
Study 20693248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 18273622 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injections of ranibizumab (3 injections)
Number of subjects: 29
Study 16828478 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OCs) for 21 days
Number of subjects: 85
Study 16828478 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRH-a) for 14 days
Number of subjects: 85
Study 16828478 — intervention group
Group type: COMPARATOR
Intervention: Basal state
Number of subjects: 85
Study 12724464 — intervention group
Group type: EXPERIMENTAL
Intervention: Methamphetamine dependence
Number of subjects: 27
Study 12724464 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 27
Study 11106130 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (0.6, 1.2, 1.8, 2.4, and 3.0 microg/kg)
Number of subjects: 12
Study 11106130 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (0.4, 0.8, 1.3, 2.0, 3.0, and 4.5 microg/kg)
Number of subjects: 12
Study 11106130 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9082867 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose spinal anaesthesia (n = 150)
Number of subjects: 300
Study 9082867 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous spinal anaesthesia (CSA) (n = 150)
Number of subjects: 300
Study 7831427 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine abstinence for 12 hours
Number of subjects: 20
Study 7831427 — intervention group
Group type: COMPARATOR
Intervention: Normal smoking for 12 hours (Control)
Number of subjects: 20
Study 3090127 — intervention group
Group type: COMPARATOR
Intervention: Balloon reservoir volume of 3 l
Number of subjects: 20
Study 3090127 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon reservoir volume of 6 l
Number of subjects: 20
Study 3090127 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon reservoir volume of 12 l
Number of subjects: 20
Study 3090127 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon reservoir volume of 18 l
Number of subjects: 20
Study 3090127 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon reservoir volume of 24 l
Number of subjects: 20
Study 30240526 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS (10 high frequency sessions over the left dorsolateral prefrontal cortex)
Number of subjects: 39
Study 30240526 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 39
Study 26684635 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylsulfonylmethane (5 g) and Boswellic acids (7.2 mg)
Number of subjects: 120
Study 26684635 — intervention group
Group type: COMPARATOR
Intervention: Glucosamine sulfate (1500 mg)
Number of subjects: 120
Study 24457893 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-based composite restorations
Number of subjects: 534
Study 24457893 — intervention group
Group type: COMPARATOR
Intervention: Amalgam restorations
Number of subjects: 534
Study 24457893 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventative resin restorations
Number of subjects: 534